CHARMAINE GILMORE: Open Payments
NPI 1861937021 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,866 in 129 payments from 23 companies in 2025. Trend: 2023 $1,359 · 2024 $856 · 2025 $2,866
Food & beverage: $2,866
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $324 |
| AstraZeneca Pharmaceuticals LP | 7 | $245 |
| Verona Pharma, Inc. | 9 | $207 |
| GENZYME CORPORATION | 8 | $198 |
| JAZZ PHARMACEUTICALS INC. | 7 | $196 |
| Insmed, Inc. | 11 | $178 |
| Viatris Specialty LLC | 10 | $176 |
| Grifols USA, LLC | 9 | $170 |
| GlaxoSmithKline, LLC. | 11 | $162 |
| Actelion Pharmaceuticals US, Inc. | 5 | $148 |
Products named: DUPIXENT, Ohtuvayre, XYWAV, YUPELRI, Prolastin-C Liquid, OFEV, AIRSUPRA, ACTHAR.
Industry payments across FL — which companies pay providers there.
